StockGuide AI
Seguir acciones
EN RU ES
Vaxcyte

Vaxcyte

Precio: 47.29

Empresa y modelo de negocio

Vaxcyte, Inc. is a biotechnology company focused on developing innovative vaccines to address infectious diseases. Its core products include a pipeline of vaccine candidates targeting various pathogens, with a primary emphasis on pneumococcal disease. The company operates within the healthcare sector, primarily generating revenue through research and development activities and potential future product sales.

Perfil de inversión

The investment profile of Vaxcyte is more aligned with growth investors, given its focus on developing new vaccine technologies and the potential for significant future revenue from successful product launches. The stock may appeal to those with a medium to long-term investment horizon, as the company is still in the development phase. Liquidity is moderate, suitable for investors with basic to advanced experience in the biotech sector.

Sitio oficial

Métricas fundamentales

EPS (TTM) — ganancias por acción de los últimos 12 meses, $
-6.89 Riesgo
Sorpresa EPS
-29.7% peor de lo esperado
Volatilidad 20d
3.0% estable
Datos FMP / FinFeed actualizados: 2026-06-06
Recomendación: Vender Potencial: 30 Riesgo: 73 Actualizado: 2026-06-11 05:24
Cómo funciona la recomendación
Por qué la IA piensa así:
Weak fundamentals and negative momentum raise significant concerns.

Seguir en portafolio

Gráfico de precio

Recomendación IA Pronóstico de analista Evento de calendario Señal positiva Señal negativa Neutral / actualización Mantener / informativo B My buy S My sell
Cambios de recomendación IA
Fecha Antes Después Razón
2026-06-03 02:49 Mantener Vender scenario_deterioration
2026-05-28 02:54 Vender Mantener Weak fundamentals and negative momentum raise concerns.
2026-05-20 02:53 Mantener Vender scenario_deterioration
Pronósticos de analistas
Fecha Analista Acción Objetivo Precio entonces
2026-02-25 19:27 BTIG Objetivo aumentado — → 89 63.04
2025-11-19 10:23 Leerink Partners Objetivo aumentado — → 77 49.53